Joyspan Longevity - Why the Longevity Industry Is Finally Reckoning With Its Own Blind Spot

From Lifespan to Joyspan: Why the Longevity Industry Is Finally Reckoning With Its Own Blind Spot

Date: Jun 26, 2026

The Global Wellness Summit’s 2026 forecast named something that those of us working inside this field have been observing for a while: a turn away from relentless tracking, and toward a more honest conversation about joyspan and longevity — about what a long life is actually for.

The report calls it explicitly, a backlash against over-optimisation, a return of pleasure and joy, a recognition that wellness experiences should “embrace what humans actually are: imperfect, emotional, relational and sensory.” The shift is being named at industry level. And it is long overdue.

I have been saying a version of this for years. Not because I am against the tools, I use them, I value them, I prescribe them, but because tools without a coherent philosophy about what they are serving become an end in themselves. And that, in much of the wellness world, is precisely what has happened.

Twenty years inside this field

I have worked at the intersection of medicine, performance, and longevity for over two decades. I trained as a medical doctor, then in psychiatry, then in sports medicine, then in integrative and functional medicine. I competed as an elite athlete. I have sat inside the optimisation world from multiple angles, as a clinician, as an athlete, as a patient, and increasingly as someone trying to articulate a more complete picture of what health actually means.

I have seen this industry at its most rigorous and at its most reductive. I have watched blood testing become democratised and genuinely life-changing for the patients who needed it. I have also watched people pursue biological age scores with the same compulsive energy they once directed at calorie counting, with similarly limited returns on wellbeing.

And I know this terrain not only professionally. I know it from the inside.

In 2004, I sustained a traumatic brain injury. What followed was a long, disorienting, and ultimately clarifying process of recovery, one that no protocol could navigate for me. The tools helped where they could. The data informed where it was relevant. But what actually moved things was something far less quantifiable: learning, very slowly, to listen to my body rather than override it. To respond rather than simply push.

That distinction, between responding and pushing, is at the heart of what I now call BioHarmony. And it is what the wellness industry is, finally, beginning to find its way toward.

Joyspan Longevity: What you cannot biohack

The nervous system does not respond to discipline in the way optimisation culture tends to imply.

You cannot instruct your autonomic nervous system to feel safe. You can create the conditions for safety, through genuine regulation, through rest that actually restores, through authentic connection, through the things that matter to you rather than the metrics standing in for them, but forcing the outcome through more data, more interventions, and more protocol compliance often has the opposite effect. It keeps the nervous system in a low-grade state of vigilance that looks like health on a dashboard while quietly accumulating a biological cost that eventually shows up somewhere.

This is what the Summit’s 2026 forecast is beginning to acknowledge. The industry is pivoting, in their words, toward “meaning over measurement, catharsis over clinical data, self-expression over self-surveillance.” These are not soft concepts. They map directly onto what we know about nervous system biology, oxytocin, vagal tone, and the physiology of genuine restoration.

The biology of joyspan: why this is not a soft argument

Joy and pleasure are not rewards we earn after the health work is done. They are, in a very literal biological sense, part of the health work. Joyspan and longevity are not separate destinations.

Social connectedness is directly associated with vagal tone, a measurable indicator of parasympathetic nervous system activity and a predictor of cardiovascular health, immune resilience, and emotional regulation. High vagal tone is associated with better heart rate variability, lower inflammatory markers, and more robust recovery from physical and psychological stress. And vagal tone is built not through more discipline, but through warm, genuine human connection, through laughter, through physical touch, through the felt sense of being safely seen by another person.

Oxytocin, released through genuine intimacy, through the warmth of trusted relationships, through play and physical contact, downregulates the sympathetic stress response and actively supports the parasympathetic repair state. It is, in this sense, one of the most potent anti-inflammatory compounds the body produces. And it cannot be supplemented. It requires relationship.

The nervous system settles faster under genuine pleasure than under imposed discipline. This is not a metaphor. It is measurable, in HRV readings, in cortisol rhythms across the day, in inflammatory markers, in the architecture of deep sleep. When I ask patients where in their week they experience genuine joy, not achievement, not completion, not the relief of a task done, but actual pleasure and aliveness, and they struggle to answer, that is clinical information. It tells me something about why the other interventions are not holding.

Women’s biology, finally getting its own lane

The 2026 forecast also names something I have advocated for throughout my career: that longevity medicine has been built almost entirely on male biology, extrapolated to women with insufficient scrutiny and frequently inadequate outcomes.

Research is mounting that women age fundamentally differently. The ovary functions as what researchers now describe as a command centre for women’s systemic health, and its decline during perimenopause and menopause triggers a cascade of changes that existing longevity protocols, designed primarily around men in their thirties and forties, were never equipped to address.

Cardiovascular risk profile shifts dramatically. Metabolic function changes. Bone density trajectories alter. Cognitive resilience is affected by hormonal withdrawal in ways that remain underappreciated and undertreated in mainstream medicine. Sleep architecture deteriorates. Body composition changes in ways that are genuinely resistant to the interventions that worked earlier in life, because the hormonal substrate has changed.

This year, the field is beginning to course-correct. Clinics, wearable companies, diagnostics providers, and wellness programmes are all reorienting toward female biology. For me, this is not a trend. It is a correction that was long overdue, and one I welcome, not least because I am living this biology myself.

What joyspan longevity means in practice

I want to be precise about what I mean by joyspan, because it is easy to hear it as a soft add-on to more serious health work. It is not.

Lifespan is the number of years you live. Healthspan is the number of those years you live without significant disease or disability. Joyspan, the term I have been using with patients for some time, and that I believe deserves to become part of the field’s vocabulary, is the capacity to feel genuinely energised, purposeful, and present across those decades. Joyspan and longevity are the same project, not competing ones. Not merely free from disease. Not merely functional. But in active contact with your own life, able to experience it with some degree of pleasure, meaning, and connection.

The distinction matters clinically because many people optimising for lifespan and healthspan are not optimising for joyspan at all. They are highly functional, measurably healthy by conventional markers, and quietly depleted. Something that was once meaningful has been replaced by its metric. The life being optimised for has shrunk to the dimensions of what can be tracked.

That is not what longevity medicine should be producing. And the fact that the industry is beginning to name this, to acknowledge that the goal was always the quality of the life, not just its length, feels like a meaningful shift.

The longevity industry has spent a decade telling us to optimise. It is now beginning to ask what for. That is a more interesting question. And I believe the answer, when we are honest about both the science and the lived experience, is joyspan. A longevity that points toward something that looks less like a protocol and more like a life.


The Global Wellness Summit 2026 report is worth reading in full for the broader industry context. At Wellgevity, we work with a small number of clients through the BioHarmony Method, an integrated approach to longevity that takes in biology, nervous system health, emotional wellbeing, and the things that make a life worth extending. If you would like to explore working with us, you can apply here.

Leave a Reply

Your email address will not be published. Required fields are marked *

EthicSerifItalic